Literature DB >> 2900811

First domain encoding sequence mediates human class II beta-chain gene cross-hybridization.

E Turco1, R Fritsch, M Trucco.   

Abstract

HLA class II molecules are surface heterodimers which are essential in the initiation of immune responses. The amount of polymorphism expressed by the different class II molecules is largely dependent on the polymorphic structure of their beta chains. Cross-hybridization between class II beta genes frequently hampered restriction fragment length polymorphism analysis of donor genomic DNA. In this report we show that the cross-hybridization between human class II beta genes is mediated by a region of high homology, rich in C and G residues, between the first domain encoding sequences of DP, DQ, and DR genes. The removal of the DNA segment containing this region from the fragments used as labeled probes against the corresponding fragments of the genes at other loci or against endonuclease digested genomic DNA completely eliminated or drastically reduced the cross-hybridization. Also, the RFLP patterns generated with the shortened probes were more informative and much simpler to interpret than were these generated with probes made from the original genes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900811     DOI: 10.1007/bf00375859

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  17 in total

Review 1.  DNA polymorphism of HLA class I and class II regions.

Authors:  D Cohen; P Paul; I Le Gall; A Marcadet; M P Font; O Cohen-Haguenauer; B Sayagh; H Cann; J M Lalouel; J Dausset
Journal:  Immunol Rev       Date:  1985-07       Impact factor: 12.988

Review 2.  Structure, sequence and polymorphism in the HLA-D region.

Authors:  J Trowsdale; J A Young; A P Kelly; P J Austin; S Carson; H Meunier; A So; H A Erlich; R S Spielman; J Bodmer
Journal:  Immunol Rev       Date:  1985-07       Impact factor: 12.988

3.  DQ alpha and beta RFLP reveals the composition of the DQ molecule recognized by T-cell clones.

Authors:  S Rosenshine; I Cascino; A Zeevi; R J Duquesnoy; M Trucco
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Polymorphisms of the HLA-DQ subregion.

Authors:  M Trucco; R Duquesno
Journal:  Immunol Today       Date:  1986-10

5.  Clusters of HLA class II beta restriction fragments describe allelic series.

Authors:  D Cohen; I Le Gall; A Marcadet; M P Font; J M Lalouel; J Dausset
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

6.  Structural relationship of the SB beta-chain gene to HLA-D-region genes and murine I-region genes.

Authors:  E O Long; J Gorski; B Mach
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

7.  Six HLA-D region alpha-chain genes on human chromosome 6: polymorphisms and associations of DC alpha-related sequences with DR types.

Authors:  R S Spielman; J Lee; W F Bodmer; J G Bodmer; J Trowsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes.

Authors:  E O Long; C T Wake; J Gorski; B Mach
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains.

Authors:  L Schenning; D Larhammar; P Bill; K Wiman; A K Jonsson; L Rask; P A Peterson
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

Review 10.  Genetic complexity and expression of human class II histocompatibility antigens.

Authors:  A J Korman; J M Boss; T Spies; R Sorrentino; K Okada; J L Strominger
Journal:  Immunol Rev       Date:  1985-07       Impact factor: 10.983

View more
  1 in total

1.  Full length beta chain cDNAs of DQw9 and DQw8 molecules encode proteins that differ only at amino acid 57.

Authors:  R Giorda; E Turco; M Trucco
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.